These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15668890)

  • 1. Overexpression of clusterin in human hepatocellular carcinoma.
    Kang YK; Hong SW; Lee H; Kim WH
    Hum Pathol; 2004 Nov; 35(11):1340-6. PubMed ID: 15668890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma.
    Xie D; Lau SH; Sham JS; Wu QL; Fang Y; Liang LZ; Che LH; Zeng YX; Guan XY
    Cancer; 2005 Jan; 103(2):277-83. PubMed ID: 15578711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
    Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
    Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of ezrin expression in human hepatocellular carcinoma.
    Kang YK; Hong SW; Lee H; Kim WH
    Mol Carcinog; 2010 Sep; 49(9):798-804. PubMed ID: 20572160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The detection of protein expression of clusterin and Ki-67 and the status of cell apoptosis in bladder transitional cell carcinoma].
    Chen W; Xie D; Luo JH; Wang CX; Tao Y; Zheng KL; Mei H
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):111-4. PubMed ID: 16620672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hépatocellulaire.
    Chapel F; Guettier C; Chastang C; Rached AA; Mathieu D; Tepper M; Beaugrand M; Trinchet JC
    Cancer; 1996 Mar; 77(5):864-71. PubMed ID: 8608476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension.
    Kurahashi T; Muramaki M; Yamanaka K; Hara I; Miyake H
    BJU Int; 2005 Oct; 96(6):895-9. PubMed ID: 16153225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AKR1B10 expression is associated with less aggressive hepatocellular carcinoma: a clinicopathological study of 168 cases.
    Schmitz KJ; Sotiropoulos GC; Baba HA; Schmid KW; Müller D; Paul A; Auer T; Gamerith G; Loeffler-Ragg J
    Liver Int; 2011 Jul; 31(6):810-6. PubMed ID: 21645211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclo-oxygenase-2 overexpression is a feature of early and well-differentiated hepatocellular carcinoma with a favourable prognosis.
    Schmitz KJ; Wohlschlaeger J; Lang H; Sotiropoulos GC; Kaiser GM; Schmid KW; Baba HA
    J Clin Pathol; 2009 Aug; 62(8):690-3. PubMed ID: 19638539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
    Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
    Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
    Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer.
    Miyagawa S; Soeda J; Takagi S; Miwa S; Ichikawa E; Noike T
    Hum Pathol; 2004 Nov; 35(11):1392-6. PubMed ID: 15668897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH; Jeng YM; Chen HL; Lai PL; Pan HW; Hsieh FJ; Lin CY; Lee PH; Hsu HC
    J Pathol; 2006 Aug; 209(4):549-58. PubMed ID: 16739096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of different clusterin isoforms in human colon tumorigenesis.
    Pucci S; Bonanno E; Pichiorri F; Angeloni C; Spagnoli LG
    Oncogene; 2004 Mar; 23(13):2298-304. PubMed ID: 14755245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
    Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
    Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
    Chan KL; Guan XY; Ng IO
    Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL; Tai MH; Huang CC; Wang CC; Lin JW; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
    J Surg Oncol; 2008 Oct; 98(5):349-57. PubMed ID: 18646041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.